Our study adds to the growing body of data indicating that SARM1 inhibitors may also be of use in retinal degenerative diseases that have a SARM1 dependent component (Ozaki et al., 2020; Sasaki et al., 2020) making SARM1 a potential therapeutic target of interest for future study in retinal degeneration. Here, SARM1 is linked to retinal degeneration.